Pharming Group N.V.
PHARM.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 4.4% | 17.9% | -14.7% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 92.7% | 90.4% | 89.5% | 86.8% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | -€0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | -€0 |
| Other Operating Expenses | -€0 | -€0 | -€0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | €0 | €0 | -€0 | €0 |
| % Margin | 16.3% | 11.6% | -8.9% | 7.2% |
| Other Income/Exp. Net | -€0 | -€0 | -€0 | -€0 |
| Pre-Tax Income | €0 | €0 | -€0 | €0 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | €0 | €0 | -€0 | €0 |
| % Margin | 7.8% | 5% | -18.6% | 3.1% |
| EPS | 0.011 | 0.007 | -0.022 | 0.005 |
| % Growth | 61.4% | 131.8% | -558.3% | – |
| EPS Diluted | 0.011 | 0.007 | -0.022 | 0.005 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | €0 | €0 | -€0 | €0 |
| % Margin | 24.1% | 10.5% | -5.2% | 16.9% |